Cipla SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP

Published by MBA Skool Team, Last Updated: April 12, 2020

SWOT analysis of Cipla analyses the brand/company with its strengths, weaknesses, opportunities & threats. In Cipla SWOT Analysis, the strengths and weaknesses are the internal factors whereas opportunities and threats are the external factors.

SWOT Analysis is a proven management framework which enables a brand like Cipla to benchmark its business & performance as compared to the competitors and industry. As of 2020, Cipla is one of the leading brands in the pharma and healthcare sector.

The table below lists the SWOT (Strengths, Weaknesses, Opportunities, Threats), top Cipla competitors and includes Cipla target market, segmentation, positioning & Unique Selling Proposition (USP).

Cipla SWOT Analysis, Competitors, Segmentation, Target Market, Positioning, USP & Brand Analysis Table
Cipla Brand Analysis
Parent Company

Cipla

Category

Pharmaceuticals

Sector

Pharma and Healthcare

Tagline/ Slogan

Caring for life

USP

Commitment to make medicines affordable and accessible particularly to cancer patients

Cipla STP
Cipla Segmentation

AIDS, respiratory disease, cancer cardiovascular disease, arthritis

Target Group

Customers of various flavors and fragrances, OTC products, prescription products, pesticides, agrochemicals, doctors

Cipla Positioning

They use latest technology to concentrate all their knowledge of over seven decades in developing life saving drugs

Cipla SWOT Analysis
Cipla Strengths

Below are the Strengths in the SWOT Analysis of Cipla:

1. Cipla has developed good positive image by providing support to cancer patients by issuing drugs at low cost
2. Imminent commencement of the Fixed-Dose combination for treatment of uncomplicated P. falciparum malaria to tackle the 200+ million cases of malaria globally

3. Initiation of ‘No Touch Breast Scan’ a step forward in the screening technology in India.
4. A foremost player in anti-infective and anti-asthmatic formulations.
5. Has a strong employee force of over 16,000

Cipla Weaknesses

Here are the weaknesses in the Cipla SWOT Analysis:

1. Strong competition from international and domestic giants means limited market share

2. Cipla had faced problems during negative campaign by AHF

Cipla Opportunities

Following are the Opportunities in Cipla SWOT Analysis:

1. It can venture into Alzheimer’s disease medication
2. They can use Viramune generic to achieve higher growth.

3. Increased investment in the budding markets, to push expansion in the global economy

Cipla Threats

The threats in the SWOT Analysis of Cipla are as mentioned:

1. Constant price rises in the Indian country is taking its toll and compounding the problem
2.The Indian Rupee depreciated as compared to the US Dollar

3. Fluctuations in currency exchange rates have a noteworthy impact on the Company’s operations and financial results.

Cipla Competition
Competitors

Below are the top 4 Cipla competitors:

1. Sun Pharmaceuticals
2. Dr. Reddy’s laboratories

3. Lupin

4. Ranbaxy labs


This article has been researched & authored by the Content & Research Team. It has been reviewed & published by the MBA Skool Team. The content on MBA Skool has been created for educational & academic purpose only.

Similar analysis has also been done for the competitors of the company belonging to the same category, sector or industry. Browse marketing analysis of more brands and companies similar to Cipla. The BrandGuide section covers SWOT Analysis, Competitors, Segmentation, Target Market, Positioning & USP of more than 2800 brands from over 20 industry sectors.

Search & Explore : BrandGuide


The brand names and other brand information used in the BrandGuide section are properties of their respective companies. The companies are not associated with MBA Skool in any way.
Edit the Brand or Add a New One : Contribute to BrandGuide
Share this Page on:
Facebook ShareTweetShare on Linkedin